News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, August 6, 2018

 

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Grants are accepted for research, equipment, and travel/education, and other areas.

Grant proposal deadline is September 6, 2018 for grants starting January 1, 2019. 

For additional information go to:

http://www.ocascr.org/grants/grant-application-information/

 

 

NIH – Where do I Put the Information I know You’d Want, But Didn’t Ask For? 

The applicable application guide and funding opportunity announcement provide very specific

guidance on what to include in your application and, in some cases, there are page limits you

must stay within to convey the requested information.

If you have information that doesn’t fit in page-limited attachments like your Specific Aims and

Research Strategy, rework those attachments until you tell the best story possible within the

confines of the page limits. Do not try to stuff that extra information into other non-limited fields

of the application forms. Similarly, if you have information that doesn’t have a “natural home”

based on our instructions, don’t include it.

There are several form fields with tempting names like “Appendix,” “Other Attachments,” “Other

Requested Information,” and “Other Clinical Trial-related Attachments.” DO NOT use those fields

unless requested to do so in the application guide or announcement.

Why not? Even if you have the best of intentions, you need to resist the temptation to force fit

information into your application where it doesn’t belong. The page limits and guidance are there

for fairness and you may find your application pulled from consideration if you try to get around them.

https://grants.nih.gov/grants/guide/notice-files/not-od-11-080.html

 

 

IRB Announcement for iRIS Users: NEW! Incident Report Form, Effective Aug. 7, 2018:

The submission process for reporting Protocol Deviations and Unanticipated Problems (UP) is changing!

The IRB Office is rolling out a combined form called the HSC Incident Report Form.

Investigators should use this form beginning Tuesday, August 7th, when reporting deviations and UPs to the IRB.

iRIS users must be careful, though! The previous forms for Protocol Deviations and UPs will still be

accessible in the list of submission forms.

These forms have been renamed to include ‘NC’ to indicate that they are now for the Norman Campus only.

Please note that the IRB Office will not accept any Protocol Deviation Reports or UP Reports after August 7th

Events reported on these forms will be withdrawn and you will be asked to use the new HSC Incident Report Form.

Please contact the IRB Office at IRB@ouhsc.edu or 405-271-2045 if you have any questions.

 

 

SBIR Opportunties from NIH and DoE

NIH Contract SBIR Solicitation & Detailed Topic Descriptions – Proposals Due October 22, 2018 by 5PM

https://sbir.nih.gov/sites/default/files/PHS2019-1.pdf

DoE SBIR Solicitation Detailed Topic Descriptions – Mandatory Letter of Intent Due September 04, 2018,

Proposals Due October 15, 2018

https://science.energy.gov/~/media/sbir/pdf/TechnicalTopics/FY2019_Phase_1_Release_1_Topics.pdf

If interested in any of these opportunities or any other SBIR opportunities (e.g. the NIH grant SBIR solicitation

due September 5), please contact Thomas Wavering, Executive Director, Tom Love Innovation Hub, University

of Oklahoma at wavering@ou.edu or 405-325-3980.  In addition, there may programs through the Oklahoma

Catalyst Programs, run out of the Innovation Hub,that may be able to provide some assistance.

 

 

OSCTR TPIR Trainee Program

Seeking applicants for the fifth year of the research training program Translating Practice into

Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic

Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant.

The goal of the TPIR trainee program is to produce a group of clinicians and scientists who have

the ability to translate their clinical observations and ideas for improving practice into practical and

feasible research projects. Attached is a detailed description and application due September 4, 2018.

http://osctr.ouhsc.edu/translating-practice-research-program

https://research.ouhsc.edu/Portals/1329/Assets/Documents/OSCTR TPIR information 2018.pdf?ver=2018-07-30-073037-033

 

We are pleased to share the summer issue of Research News highlighting the outstanding research

activities across the University of Oklahoma Health Sciences Center (OUHSC). The purpose of this

quarterly newsletter is to inform you of the exciting research and scholarly work being conducted by

our OUHSC faculty, students, and staff. 

If you are interested in having your work or that of your peers, staff, and/or students published in the

newsletter or publishing a research related press release, please contact Samantha Skrepnek at

Samantha-Skrepnek@ouhsc.edu.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Research News_Summer 2018 Issue.pdf?ver=2018-08-06-073215-657

 

Applications for PHF Bridge Grant

Proposal Deadline Friday, August 17, 2018

The primary objective of the PHF Bridge Grant program is to provide funding of limited duration to

enhance OUHSC faculty competitiveness for NIH R01 and Department of Defense (DoD) extramural

funding.  PHF Bridge Grant funding is specifically for those OUHSC faculty members who have

submitted R01 applications to NIH or applications to DoD that have been reviewed and scored,

but not funded.   Applicants may request support of up to $75,000 for one year.

Guidelines and Application Form is attached or go to:

http://research.ouhsc.edu/ResearchAdministration/Grants/FundingSources/PHFGrantInformation.aspx

https://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF-Bridge Grant-Guidelines - Final - August-September 2018.docx?ver=2018-07-23-073457-197

 

NIH NOTICES

 

NIH/AHRQ Application Submission/Resubmission Policy (NOT-OD-18-197)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-197.html

 

NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization

Accelerator Program (CAP) 2018-2019 (NOT-OD-18-213)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-213.html

 

Update on NIHs Next Generation Researchers Initiative (NGRI) Policy on Early Established

Investigators (EEIs) (NOT-OD-18-214)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-214.html

 

Notice of Additional Guidance for Alzheimer's Clinical Trials Consortium (ACTC) Applicants

(NOT-AG-18-023)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-023.html

 

NIAID T32 and T35 Training Grants Maximum Number of Trainee Slots (NOT-AI-18-044)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-044.html

 

Notice of Change in Key Dates in PA-18-842 "Administrative Supplements to Support Cancer

Disparity Collaborative Research" (NOT-CA-18-090)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-090.html

 

NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data

Aggregator (NOT-CA-18-095)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-095.html

 

Update on the National Cancer Institute (NCI) "PREVENT Cancer Preclinical Drug Development

Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing"

(NOT-CA-18-096)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-096.html

 

Request for Information (RFI): Strategies for Advancing Sepsis Research Supported by NIGMS

(NOT-GM-18-039)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-18-039.html

 

Notice of Change of Application Due Date for RFA-HD-19-018: Using Archived Data and Specimen

Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)

(NOT-HD-18-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-015.html

 

Notice of Clarification of AIDS Receipt Dates for PAR-18-844-Investigator Initiated Research in

Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) (NOT-HG-18-012)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-18-012.html

 

Notice of Change of Key Dates to RFA-HL-18-023 "Stimulating Access to Research in Residency

(StARR) (R38)" (NOT-HL-18-639)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-639.html

 

Confidentiality in AHRQ-Supported Research (NOT-HS-18-012)
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-012.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/

Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)

(NOT-MH-18-037)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-037.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/

Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)

(NOT-MH-18-038)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-037.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care

Approaches to Advanced Signs and Symptoms (R01- Clinical Trial Optional) (NOT-NR-18-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-013.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care

Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) (NOT-NR-18-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-014.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for NINR Clinical Trial Planning

Grant (R34- Clinical Trial Optional) (NOT-NR-18-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-015.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Analytical and Clinical Validation

of Biomarkers, Biomarker Signatures, and Endpoints for Pain Indications (R61/R33) (NOT-NS-18-074)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-074.html

 

Soliciting Feedback on the BRAIN Initiative (NOT-NS-18-075)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-075.html

 

Notice of Change of Requirements and Interest in Small Business Innovation Research (SBIR) and

Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management

and Improved Treatments for Opioid Misuse and Addiction (NOT-NS-18-076)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-076.html

 

Notification that NINDS will Accept Postdoctoral Fellowship Applications (F32; PAR-16-458) in

October 2018 from all Potential Applicants who Meet the Eligibility Requirements for the August 2018

Due Date NOT-NS-18-079)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-079.html

 

Notice Announcing Partnership Opportunity for Device-Based Clinical Studies Issued for the

Stimulating Peripheral Activity to Relieve Conditions Program (NOT-RM-18-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-18-019.html

 

Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development

of Tissue Chips to Model Nociception, Opioid Addiction and Overdose (NOT-TR-18-027)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-18-019.html

 

Notice of Modification to RFA-TR-18-020 Rare Diseases Clinical Research Consortia (RDCRC) for the

Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) (NOT-TR-18-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-18-030.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR)

(R03 Clinical Trial Optional) (RFA-AG-19-021) – Deadline October 23, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-021.html

 

HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)

(RFA-AI-18-029) – December 5, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-18-029.html

.

Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases

(R61/R33 Clinical Trial Not Allowed) (RFA-AR-19-012) – Deadline April 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-012.html

 

Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical

Trial Not Allowed) (RFA-DK-18-012) – Deadline November 8, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-012.html

 

Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional)

(RFA-HD-19-008) – Deadline October 1, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-008.html

 

Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed) (RFA-HG-18-008)

Deadline November 8, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-008.html

 

Molecular Atlas of Lung Development Program (LungMAP) Phase 2 Research Centers

(U01- Clinical Trial Not Allowed) (RFA-HL-19-020) – Deadline October 31, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-020.html

 

Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core

(U01- Clinical Trial Not Allowed) (RFA-HL-19-021) – Deadline October 31, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-021.html

 

Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center

(U24- Clinical Trial Not Allowed) (RFA-HL-19-022) – Deadline October 31, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-022.html

 

Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic

Cell Genome Editing (U01 Clinical Trial Not Allowed) (RFA-RM-18-022) – Deadline October 18, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-022.html

 

Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and

Tissues (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-18-023) – Deadline October 18, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-023.html

 

Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed)

(RFA-RM-18-024) – Deadline October 18, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-024.html

 

Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo

(UH2/UH3 Clinical Trial Not Allowed) (RFA-RM-18-025) – Deadline October 18, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-025.html

 

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program

(U24 Clinical Trial Not Allowed) (RFA-RM-18-030) – Deadline October 31, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-030.html

 

Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial

Not Allowed) (PA-18-867) – Deadline October 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-867.html

 

Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial

Not Allowed) (PA-18-868) – Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-868.html

 

BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for

Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed) (PA-18-870)

Deadline September 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-870.html

 

BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for

Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed) (PA-18-871)

Deadline September 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-871.html

 

Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) (PA-18-872)

Deadline October 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-872.html

 

Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) (PA-18-873)

Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-873.html

 

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial

Not Allowed) (PA-18-874) – Deadline October 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-874.html

 

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial

Not Allowed) (PA-18-876) – Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-876.html

 

Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases

(X02 Clinical Trial Not Allowed) (PAR-18-866) – Deadline October 4, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-866.html

 

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) (PAR-18-869)

Deadline November 7, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-869.html

 

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial

Not Allowed) (PAR-18-875) – Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-875.html

 

Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline

(R01 Clinical Trial Optional) (PAR-18-877) – Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-877.html

 

Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline

(R01 Clinical Trial Required) (PAR-18-878) – Deadline October 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-878.html

 

Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)

(PAR-18-879) – Deadline December 3, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-879.html

 

 .

OTHER FEDERAL DEADLINES

 

Department of Defense (DOD) – Gulf War Illness Research Program – New Investigator Award

Required Pre-Application due October 18, 2018 and Full Proposal Deadline is November 8, 2018

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=164900

 

DOD – Vision Research Program – Focused Translational Team Sciences Award (FTTSA)

Required Pre-Application due September 4, 2018 and Full Proposal Deadline is December 4, 2018

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=180900

 

DOD – Vision Research Program – Investigator Initiated Research Award (IIRA)

Required Pre-Application due September 4, 2018 and Full Proposal Deadline is December 4, 2018

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=180900

 

 

New Clinical Study Opportunities

 

***************************************************************

Please note this is NOT a solicitation for study subjects

**************************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following

clinical studies:

  • Phase IIb Clinical Study In AZD5718 (5-Lipogygenase Activating Protein), For Patients Wit

             Coronary Artery Disease (CAD) And Hospitalized For Acute Coronary Syndrome (ACS)

  • Human Papilloma Virus (HPV) 117701
  • Osteoporosis postmenopausal  00114071
  • Acute coronary syndrome  00114806
  • Melanoma  00113464
  • Chronic renal failure  00111552
  • Non-Hodgkin lymphoma  00115736
  • Crohn's disease  00110979
  • Dermatitis  00105496
  • Rheumatoid arthritis  00114994

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on

any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed

to the Office of Research Administration.

Print

Name:
Email:
Subject:
Message:
x